Page last updated: 2024-11-02

pifithrin and Obesity

pifithrin has been researched along with Obesity in 1 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homayounfar, R1
Jeddi-Tehrani, M1
Cheraghpour, M1
Ghorbani, A1
Zand, H1

Other Studies

1 other study available for pifithrin and Obesity

ArticleYear
Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic and oncogenic signaling of insulin.
    General and comparative endocrinology, 2015, Apr-01, Volume: 214

    Topics: Adipose Tissue; Adiposity; Animals; Benzothiazoles; Body Weight; Diet, High-Fat; Fluorescent Antibod

2015